Nuclear Factor Erythroid 2-Related Factor (NRF2), Heme Oxygenase 1 (HO-1) and Total Oxidant-Antioxidant Status in Patients with COVID-19
Introduction: Studies on nuclear factor erythroid 2-related factor 2 (Nrf2) and heme
oxygenase-1 (HO-1) levels in COVID-19 patients are limited. This study aimed to investigate …
oxygenase-1 (HO-1) levels in COVID-19 patients are limited. This study aimed to investigate …
[HTML][HTML] Dynamic thiol disulphide homeostasis in the follow-up of the prognosis of patients treated for COVID-19 in the intensive care unit
Introduction: Evaluation of the prognosis in the early period of intensive care patients and
arranging the treatment accordingly is of vital importance. In the present study, we …
arranging the treatment accordingly is of vital importance. In the present study, we …
[HTML][HTML] Состояние антиоксидантного статуса у детей и подростков с COVID-19
ЛВ Рычкова, МА Даренская, НВ Семёнова… - Acta biomedica …, 2021 - cyberleninka.ru
Обоснование. Пандемия COVID-19, вызванная коронавирусом SARS-CoV-2, подняла
значимость данной проблемы на первую ступень и коснулась систем здравоохранения …
значимость данной проблемы на первую ступень и коснулась систем здравоохранения …
[HTML][HTML] Antioxidant status in children and adolescents with COVID-19
LV Rychkova, MA Darenskaya… - Acta biomedica …, 2021 - actabiomedica.ru
Background. The COVID-19 pandemic has raised the importance of this problem to the first
stage and has affected healthcare system around the world. Despite the more favorable …
stage and has affected healthcare system around the world. Despite the more favorable …
Среднетяжёлое и бессимптомное течение COVID-19 у женщин в менопаузе: биомаркеры системы антиоксидантной защиты
НВ Семёнова, ЕВ Вырупаева… - Acta Biomedica …, 2024 - actabiomedica.ru
МОРФОЛОГИЯ, ФИЗИОЛОГИЯ И ПАТОФИЗИОЛОГИЯ Page 1 ACTA BIOMEDICA
SCIENTIFICA, 2024, Vol. 9, N 2 112 Morphology, physiology and pathophysiology …
SCIENTIFICA, 2024, Vol. 9, N 2 112 Morphology, physiology and pathophysiology …
[PDF][PDF] Aplicación de la citometría de flujo al estudio en tiempo real de las interacciones entre especies reactivas de oxígeno y nitrógeno en el estrés oxidativo …
BJ Martínez, JEOC BLASCO, GH MARTÍN, GL RODAS - 2022 - roderic.uv.es
APLICACIÓN DE LA CITOMETRÍA DE FLUJO AL ESTUDIO EN TIEMPO REAL DE LAS
INTERACCIONES ENTRE ESPECIES REACTIVAS DE OXÍGENO Y NIT Page 1 Presentada …
INTERACCIONES ENTRE ESPECIES REACTIVAS DE OXÍGENO Y NIT Page 1 Presentada …
Prognostic value of total thiol and D-dimer in patients hospitalized with COVID-19
D Barlak Keti, S Muhtaroglu, O Yildiz… - Turkish Journal of …, 2023 - degruyter.com
Objectives The lack of specific treatment for COVID-19 and the fact that the clinical course
differs between individuals makes it difficult to predict the prognosis. The aim was to …
differs between individuals makes it difficult to predict the prognosis. The aim was to …
Характеристика процессов перекисного окисления липидов и антиоксидантной защиты у рожениц при COVID-19
НА Ишутина, ИА Андриевская… - … и патологии дыхания, 2024 - cfpd.elpub.ru
Характеристика процессов перекисного окисления липидов и антиоксидантной защиты у
рожениц при COVID-19 | Ишутина | Бюллетень физиологии и патологии дыхания …
рожениц при COVID-19 | Ишутина | Бюллетень физиологии и патологии дыхания …
Assessment of the Pro-oxidant Antioxidant Balance (PAB) in COVID-19 Patients Compared to Healthy Subjects Referred to Masih Hospital
SF Maashi, M Pourabdollah, E Askari… - Journal of Kerman …, 2023 - jkmu.kmu.ac.ir
Objective: Recent studies have shown an increase in the pro-oxidant antioxidant balance
(PAB) in patients with Covid 19 and are also associated with exacerbation of clinical …
(PAB) in patients with Covid 19 and are also associated with exacerbation of clinical …
[PDF][PDF] Development and preclinical characterization of meningococcal outer membrane vesicle vaccine
Y Özsürekci - 2024 - repository.bilkent.edu.tr
Development and preclinical characterization of meningococcal outer membrane vesicle
vaccine Page 1 DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF …
vaccine Page 1 DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF …